21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Engulfment of cerebral apoptotic bodies controls the course of prion disease in a mouse strain–dependent manner

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Progressive accumulation of PrP Sc, a hallmark of prion diseases, occurs when conversion of PrP C into PrP Sc is faster than PrP Sc clearance. Engulfment of apoptotic bodies by phagocytes is mediated by Mfge8 (milk fat globule epidermal growth factor 8). In this study, we show that brain Mfge8 is primarily produced by astrocytes. Mfge8 ablation induced accelerated prion disease and reduced clearance of cerebellar apoptotic bodies in vivo, as well as excessive PrP Sc accumulation and increased prion titers in prion-infected C57BL/6 × 129Sv mice and organotypic cerebellar slices derived therefrom. These phenotypes correlated with the presence of 129Sv genomic markers in hybrid mice and were not observed in inbred C57BL/6 Mfge8 −/− mice, suggesting the existence of additional strain-specific genetic modifiers. Because Mfge8 receptors are expressed by microglia and depletion of microglia increases PrP Sc accumulation in organotypic cerebellar slices, we conclude that engulfment of apoptotic bodies by microglia may be an important pathway of prion clearance controlled by astrocyte-borne Mfge8.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: found
          • Article: not found

          Experimental autoimmune encephalomyelitis repressed by microglial paralysis.

          Although microglial activation occurs in inflammatory, degenerative and neoplastic central nervous system (CNS) disorders, its role in pathogenesis is unclear. We studied this question by generating CD11b-HSVTK transgenic mice, which express herpes simplex thymidine kinase in macrophages and microglia. Ganciclovir treatment of organotypic brain slice cultures derived from CD11b-HSVTK mice abolished microglial release of nitrite, proinflammatory cytokines and chemokines. Systemic ganciclovir administration to CD11b-HSVTK mice elicited hematopoietic toxicity, which was prevented by transfer of wild-type bone marrow. In bone marrow chimeras, ganciclovir blocked microglial activation in the facial nucleus upon axotomy and repressed the development of experimental autoimmune encephalomyelitis. We conclude that microglial paralysis inhibits the development and maintenance of inflammatory CNS lesions. The microglial compartment thus provides a potential therapeutic target in inflammatory CNS disorders. These results validate CD11b-HSVTK mice as a tool to study the impact of microglial activation on CNS diseases in vivo.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.

            The mechanisms involved in prion neurotoxicity are unclear, and therapies preventing accumulation of PrPSc, the disease-associated form of prion protein (PrP), do not significantly prolong survival in mice with central nervous system prion infection. We found that depleting endogenous neuronal PrPc in mice with established neuroinvasive prion infection reversed early spongiform change and prevented neuronal loss and progression to clinical disease. This occurred despite the accumulation of extraneuronal PrPSc to levels seen in terminally ill wild-type animals. Thus, the propagation of nonneuronal PrPSc is not pathogenic, but arresting the continued conversion of PrPc to PrPSc within neurons during scrapie infection prevents prion neurotoxicity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.

              The 'protein only' hypothesis postulates that the prion, the agent causing transmissible spongiform encephalopathies, is PrP(Sc), an isoform of the host protein PrP(C). Protease treatment of prion preparations cleaves off approximately 60 N-terminal residues of PrP(Sc) but does not abrogate infectivity. Disruption of the PrP gene in the mouse abolishes susceptibility to scrapie and prion replication. We have introduced into PrP knockout mice transgenes encoding wild-type PrP or PrP lacking 26 or 49 amino-proximal amino acids which are protease susceptible in PrP(Sc). Inoculation with prions led to fatal disease, prion propagation and accumulation of PrP(Sc) in mice expressing both wild-type and truncated PrPs. Within the framework of the 'protein only' hypothesis, this means that the amino-proximal segment of PrP(C) is not required either for its susceptibility to conversion into the pathogenic, infectious form of PrP or for the generation of PrP(Sc).
                Bookmark

                Author and article information

                Journal
                J Exp Med
                J. Exp. Med
                jem
                The Journal of Experimental Medicine
                The Rockefeller University Press
                0022-1007
                1540-9538
                27 September 2010
                : 207
                : 10
                : 2271-2281
                Affiliations
                Institute of Neuropathology, University Hospital of Zurich, 8091 Zurich, Switzerland
                Author notes
                CORRESPONDENCE Adriano Aguzzi: adriano.aguzzi@ 123456usz.ch

                J. Kranich and N.J. Krautler contributed equally to this paper.

                J. Kranich’s present address is Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia.

                G. Miele’s present address is Translational Medicine Research Collaboration, University of Dundee, Dundee DD1 5EH, Scotland, UK.

                G. Hutter’s present address is Dept. of Neurosurgery, University Hospital of Basel, 4031 Basel, Switzerland.

                Article
                20092401
                10.1084/jem.20092401
                2947076
                20837697
                6b489197-dee9-40b9-ac9a-1b7221322a09
                © 2010 Kranich et al.

                This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites licen se for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).

                History
                : 9 November 2009
                : 11 August 2010
                Categories
                Article

                Medicine
                Medicine

                Comments

                Comment on this article